Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

HSCI 214 > Lecture 9 > Flashcards

Lecture 9 Flashcards

1
Q

Which of the following must be present as part of meeting DSM-V diagnostic criteria for schizophrenia?

A) Negative symptoms
B) Avolition
C) Catatonic behaviour
D) Delusions

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Recent estimates by the World Health Organization indicate that _________ is the number one cause of disability globally.

A) Anxiety
B) Depression
C) Cancer
D) Heart Disease

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3 major categories of mood disorders

A
  • Depressive Disorders
  • Disruptive Mood Dysregulation Disorder
  • Bipolar Disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the symptoms that must be present in MDD (major depressive disorder)?

A
  • Severely low mood AND/OR
  • Characterised by anhedonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the adjunctive symptoms of MDD?

A
  • Sense of worthlessness or guilt
  • Changes in appetite or unintentional weight change
  • Sleep disturbance (e.g., insomnia/hypersomnia)
  • Low energy
  • Slow movement
  • Poor concentration
  • Thoughts of death

Criteria
Symptoms must last at least two weeks
* Prevalence and incidence of MDD is increasing globally for all age groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give the stats for MDD

A
  • 2017: over 300 million people globally experienced clinical depression
  • 2005-2015: 18% increase in prevalence
  • WHO estimates it is the #1 cause of disability globally
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Persistent Depressive Disorder?

A

(previously dysthymia)
* Symptoms include MDD characteristics, but diagnosis requires the presence of
fewer symptoms

  • Symptoms must last at least two years (persistent)
  • feeling low, limited/excess appetite, sleep disruptions, lethargy, general sense of failure, lack of hope/faith in self/future
  • less intense than MDD but longer term
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Premenstrual Dysphoric Disorder? (PMDD)

A
  • New to DSM-V
  • Changing mood, irritability, appetite change during the luteal phase (period between ovulation and menstruation) of the menstrual cycle
  • Distinguished from Premenstrual Syndrome by the severity of symptoms and increased impact on daily functioning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the controversy around PMDD?

A

Some critics note that the addition of this “disorder” is overly medicalizing a natural biological process and stigmatizing female bodies/minds

Further controversy: creation of this diagnosis coincides with the extension of a patent for an existing medication for new use intended to treat PMDD (what medication was renamed?) (SSRI???? IDK)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Disruptive Mood Dysregulation Disorder (DMDD)

A
  • Long-standing debate: does mental illness present differently in children and youth?
  • New to DSM-V
  • Diagnosis applied to children between the ages of 6-18
  • Children with DMDD frequently exhibit extreme anger or irritability that seems disproportional to the triggering situation (described as “unwarranted”)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the controversy behind DMDD?

A

Controversy exists about this category. Some critics argue:
* It medicalizes what may be normal phases of emotional development among children and youth

  • Majority diagnosed with DMDD also match symptoms of oppositional defiant disorder
  • Children diagnosed with DMDD likely to be treated with antipsychotic medication
  • Labelling children with mental illness affects how they see the world and their interactions with others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is bipolar disorder?

A
  • Bipolar disorder involves a person who experiences episodes of mania (high energy/excitement) and episodes of depression (melancholy), previously termed “manic depression”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is hypomania

A

refers to milder forms of mania – elevated mood with lesser degrees of functional impairment
◦ E.g., Less need for sleep, higher energy and self-confidence, overly optimistic attitude

◦ Difference with mania: mania is more severe, may involve psychosis, more likely to lead to incarceration of hospitalization, treatment may differ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 3 subtypes of bipolar disorder?

A

Bipolar I

Bipolar II

Cyclothymic disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

explain Bipolar I

A

mania and depression (depression not necessary for diagnosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

explain Bipolar II

A

hypomania and more severe depression (stronger depressive symptoms, less intense mania)

17
Q

explain Cyclothymic disorder

A

The most mild form, with swings between mild depression and hypomania

18
Q

explain Eithymia

A

periods without mania and depression (APA, 2023)

19
Q

What are the different interventions that can be used to treat and manage mood disorders?

A
  • Psychotherapy, most commonly cognitive behavioural therapy
  • Psychopharmaceuticals (e.g., tricyclic antidepressants, SSRIs, and Lithium)
  • Electroconvulsive therapy (ECT) used when other treatments fail
20
Q

As described in the textbook, patient surveys have found that approximately __% prefer psychotherapy to antidepressant medication.

A

75%

21
Q

What are some of the reasons people living with depression are more likely to be prescribed antidepressants, rather than receive psychotherapy?

A
  • faster
  • fee-for-service
  • physicians don’t have much training in therapy than counsellors
  • cheaper and affordability
  • easier to change brain chemistry than behaviour
  • convenient
  • marketing strategies
  • not covered by insurance
  • lack of staff
22
Q

According to the meta-analysis conducted by Kirsch and Sapirstein (1998) that was described in the textbook, what percentage of the response to antidepressant medication was due to the placebo effect?

A

50%

23
Q

how many americans take antidepressant medications

A

1 in 10 americans

24
Q

give stats (percentages) for case study 1 about antidepressants and the placebo effect

A
  • 25% of the response to the drugs was duplicated in nontreatment control groups
  • 50% of the response to the drugs was due to the placebo effect
  • 25% of the response to the drugs was a true effect of medication
25
Q

review case study 1

A
  • Analysis of published trials of SSRIs suggest a significant benefit of medication
    over placebo
  • Analysis of all available data (published and unpublished) suggests that the
    placebo effect accounts for 80% of patient response to the medication
  • The authors point to the practice of drug manufacturers of only publishing research
    that supports claims of drug effectiveness, partially “burying” negative findings,
    which is compounded further by citation bias (smth gets cited more than the other)
  • They conclude that the evidence in favour of prescribing SSRIs is “insufficient” and recommend that psychotherapy, exercise, and acupuncture provide the same benefit, with lower risk of side effects
26
Q

case study 2: is cognitive therapy enduring or are antidepressants iatrogenic

A
  • Depression is a disorder that will often usually spontaneously remit – this means that even without treatment, it may go away on its own
  • Using antidepressant medications reduces the amount of time that patients experience depressive symptoms, compared to receiving no treatment
  • The period of time between when the medications would be effective and the depressive episode would have resolved on its own is called the continuation phase: better to stay on medications (analogy with antibiotics, symptoms are only gone because of medication)
27
Q

What happened in case study 2?

A

In this study, patients with severe depression were randomly assigned to one of three treatment groups:
* Pill placebo
* Antidepressant medication
* Cognitive Behavioural Therapy

At the end of 8 weeks, antidepressant medications were significantly more effective than placebo and slightly more effective than cognitive behavioural therapy

  • At the end of 16 weeks, cognitive behavioral therapy was slightly more effective than antidepressant medications
  • At the 16 week point, patients who had done well on antidepressant medications were randomized into either a group being withdrawn from medication to placebo, or were kept on medication
  • Patients taking placebo were much for likely to relapse
  • Patients who had done well with CBT were withdrawn from treatment and did much better than patients withdrawn from medication, but not significantly better than patients who continued on medication
  • After treatment ended, patients who did well on CBT were considerably less likely to relapse than those who did well on ADM
28
Q

What was the conclusion with case study 2

A
  • Concluded that Cognitive Behavioural Therapy has more enduring positive results and a reduced risk of relapse, compared to antidepressant medication
  • They also found that the use of medication reduces the enduring effectiveness of CBT

HSCI 214 (25 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions